Simplex Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Simplex Trading's ARKG Position: Q1 2026 in Review
Simplex Trading sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 34,278 shares — an estimated $993K sold.
Simplex Trading first reported a position in ARKG in Q3 2020 and held it in 13 quarters. The position peaked at $4.02M in Q3 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Simplex Trading reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 34,278 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $993K.
- Simplex Trading first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 13 quarters.
- Simplex Trading's ARK Genomic Revolution ETF position peaked at $4.02M in Q3 2025.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.